| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $48.7M | — | -23.5% |
| Cost of Revenue | $11.9M | — | -33.9% |
| Gross Profit | $36.8M | — | -19.4% |
| R&D Expense | $8.0M | — | -30.3% |
| SG&A Expense | $8.5M | — | -26.5% |
| Operating Income | $5.0M | — | +579.9% |
| Pre-tax Income | -$244K | — | +99.1% |
| Income Tax | $986K | — | +173.3% |
| Net Income | -$1.2M | — | +95.2% |
| EPS (Basic) | -$0.09 | — | +90.7% |
| EPS (Diluted) | -$0.09 | — | +90.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $29.8M | +1.3% | -11.6% |
| Accounts Receivable | $23.6M | -7.7% | -9.4% |
| Current Assets | $73.5M | -2.3% | -12.7% |
| Total Assets | $402.7M | -2.5% | -11.9% |
| Current Liabilities | $87.2M | -7.0% | -13.9% |
| Total Liabilities | $324.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $5.6M | — | -32.5% |
| Capital Expenditures | $81K | — | -80.9% |
| Investing Cash Flow | $96K | — | -97.5% |
| Financing Cash Flow | -$5.1M | — | +85.3% |
| Free Cash Flow | $5.5M | — | -29.9% |
| -12.3% |
| Stockholders' Equity | -$52.4M | -8.3% | -38.5% |